JP6847091B2 - グリコサミノグリカンエステル、それらを調製する方法および眼科用途のための製剤におけるそれらの使用 - Google Patents

グリコサミノグリカンエステル、それらを調製する方法および眼科用途のための製剤におけるそれらの使用 Download PDF

Info

Publication number
JP6847091B2
JP6847091B2 JP2018503836A JP2018503836A JP6847091B2 JP 6847091 B2 JP6847091 B2 JP 6847091B2 JP 2018503836 A JP2018503836 A JP 2018503836A JP 2018503836 A JP2018503836 A JP 2018503836A JP 6847091 B2 JP6847091 B2 JP 6847091B2
Authority
JP
Japan
Prior art keywords
apocarotenoid
ester
glycosaminoglycan
resin
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2018503836A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018510962A (ja
JP2018510962A5 (cg-RX-API-DMAC10.html
Inventor
ニクラ バリコルディ
ニクラ バリコルディ
ロベルト メリギ
ロベルト メリギ
Original Assignee
ヒャルブルー エス.アール.エル.
ヒャルブルー エス.アール.エル.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヒャルブルー エス.アール.エル., ヒャルブルー エス.アール.エル. filed Critical ヒャルブルー エス.アール.エル.
Publication of JP2018510962A publication Critical patent/JP2018510962A/ja
Publication of JP2018510962A5 publication Critical patent/JP2018510962A5/ja
Application granted granted Critical
Publication of JP6847091B2 publication Critical patent/JP6847091B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP2018503836A 2015-04-07 2016-04-07 グリコサミノグリカンエステル、それらを調製する方法および眼科用途のための製剤におけるそれらの使用 Expired - Fee Related JP6847091B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITFI2015A000102 2015-04-07
ITFI20150102 2015-04-07
PCT/IB2016/051960 WO2016162809A1 (en) 2015-04-07 2016-04-07 Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use

Publications (3)

Publication Number Publication Date
JP2018510962A JP2018510962A (ja) 2018-04-19
JP2018510962A5 JP2018510962A5 (cg-RX-API-DMAC10.html) 2019-05-16
JP6847091B2 true JP6847091B2 (ja) 2021-03-24

Family

ID=53719816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018503836A Expired - Fee Related JP6847091B2 (ja) 2015-04-07 2016-04-07 グリコサミノグリカンエステル、それらを調製する方法および眼科用途のための製剤におけるそれらの使用

Country Status (12)

Country Link
US (1) US10328097B2 (cg-RX-API-DMAC10.html)
EP (1) EP3280396B1 (cg-RX-API-DMAC10.html)
JP (1) JP6847091B2 (cg-RX-API-DMAC10.html)
KR (1) KR20180002674A (cg-RX-API-DMAC10.html)
CN (1) CN107636020A (cg-RX-API-DMAC10.html)
AU (1) AU2016244391B2 (cg-RX-API-DMAC10.html)
BR (1) BR112017021608A2 (cg-RX-API-DMAC10.html)
CA (1) CA2981861A1 (cg-RX-API-DMAC10.html)
ES (1) ES2888648T3 (cg-RX-API-DMAC10.html)
MA (1) MA41912A (cg-RX-API-DMAC10.html)
RU (1) RU2726192C2 (cg-RX-API-DMAC10.html)
WO (1) WO2016162809A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000012535A1 (it) * 2020-05-27 2021-11-27 Stefano Colombo Composizione oftalmica a base di acido ialuronico per la protezione dai danni causati dall’inquinamento ambientale
WO2022094695A1 (en) 2020-11-03 2022-05-12 Institut National De La Recherche Scientifique A method and a system for compressed ultrafast tomographic imaging
CN116284495B (zh) * 2023-03-20 2024-08-30 润辉生物技术(威海)有限公司 全反式维甲酸低分子透明质酸酯衍生物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1281877B1 (it) * 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
ITTS20010017A1 (it) * 2001-07-17 2003-01-17 Ct Ricerche Polytech Soc Coop Esteri polisaccaridici di acido retinoico.
ITMI20022745A1 (it) * 2002-12-23 2004-06-24 Coimex Scrl United Companies Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione.
ITMI20030043A1 (it) * 2003-01-14 2004-07-15 Coimex S C R L United Companies Uso di esteri retinoici dell'acido ialuronico in cellule
WO2005077176A1 (en) * 2004-02-11 2005-08-25 The Trustees Of Columbia University In The City Of New York Anthocyanin compounds and methods of use thereof
ITMI20040347A1 (it) * 2004-02-26 2004-05-26 Pharma Medical Ltd Nuovo farmaco di associazione
US20070207116A1 (en) * 2006-03-01 2007-09-06 Brown David C Antioxidant compositions for the eye
ITMI20062134A1 (it) * 2006-11-08 2008-05-09 Cbb Net S A Preparaziobne di esteri della diacereina con acido ialuronico e loro formulazioni per l'impiego farmaceutico
US8865685B2 (en) * 2011-06-30 2014-10-21 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
CA2886115A1 (en) * 2012-10-02 2014-04-10 Allergan, Inc. Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes

Also Published As

Publication number Publication date
EP3280396A1 (en) 2018-02-14
AU2016244391A1 (en) 2017-11-23
JP2018510962A (ja) 2018-04-19
CA2981861A1 (en) 2016-10-13
ES2888648T3 (es) 2022-01-05
AU2016244391B2 (en) 2020-11-19
US10328097B2 (en) 2019-06-25
CN107636020A (zh) 2018-01-26
RU2017138283A (ru) 2019-05-07
MA41912A (fr) 2018-02-13
WO2016162809A1 (en) 2016-10-13
BR112017021608A2 (pt) 2018-07-03
RU2017138283A3 (cg-RX-API-DMAC10.html) 2019-09-30
EP3280396B1 (en) 2021-06-23
RU2726192C2 (ru) 2020-07-09
US20180117077A1 (en) 2018-05-03
KR20180002674A (ko) 2018-01-08

Similar Documents

Publication Publication Date Title
CA2764481C (en) Pharmaceutical composition for use in medical and veterinary ophthalmology
CA2947065C (en) Aqueous ophthalmic solution and method for treating dry eye syndrome
FI79554C (fi) Foerfarande foer framstaellning av hyaluronsyrafraktioner med farmaceutisk aktivitet.
CN102256959B (zh) 用于治疗的噻吩化合物
JP6715201B2 (ja) コンドロイチン硫酸架橋体、並びにこれを含有する組成物、及び眼疾患処置剤
US10328097B2 (en) Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use
EP2542233A1 (en) Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
CA2965447A1 (en) Heat-sterilized formulation comprising chitosan and process of preparation thereof
KR20180011777A (ko) 망막 색소 상피 세포를 보호하기 위한 노르빅신 함유 조성물
CN107759665B (zh) 一种具有镇痛活性的多肽及其应用
JP7281227B2 (ja) 眼損傷用医薬品の調製におけるルテオリン-7-o-グルコシド又はルテオリン-7-o-グルクロニドの使用
JP2022125363A (ja) 眼科組成物
JPH08508505A (ja) 血管形成の抑制、制御、退化のためのヒアルロン酸およびnsaidを含有する組成物
EP0183457A2 (en) Aqueous composition containing sodium cromoglycate
CN108484795A (zh) 硫酸软骨素锂及其制备方法和应用
JP2015507070A (ja) 部分的に解重合したグリコサミノグリカン銀及び金塩
CN106540339B (zh) 一种脂肽自组装凝胶及其制备方法和应用
RU2568597C1 (ru) Фотосенсибилизатор и способ его получения
CN102716117A (zh) 柚皮素在制备抗视网膜光感受器细胞凋亡的药物中的应用
ES2773537T3 (es) Uso terapéutico de una solución oftálmica acuosa estéril
Yang et al. Vision restoration in photoreceptor-degenerated mice and macaque monkeys using nanowires
EP4135663A1 (en) Ophthalmic liquid composition comprising low molecular weight linear hyaluronic acid
Zhao et al. The Latest Research Progress on Ocular Damage Caused by LED Blue Light

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20171204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190404

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190404

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200603

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200915

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201203

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210202

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210302

R150 Certificate of patent or registration of utility model

Ref document number: 6847091

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees